International Conference on Diabetes and Endocrine Disorders (ICDED - 26)

This track will explore the latest research and clinical practices in the management of type 1 diabetes, focusing on insulin therapy and emerging technologies. Discussions will include advancements in continuous glucose monitoring and artificial pancreas systems.

This session will highlight novel therapeutic approaches for type 2 diabetes, including pharmacological interventions and lifestyle modifications. Emphasis will be placed on personalized medicine and the role of patient education in achieving glycemic control.

This track will delve into the pathophysiology of insulin resistance and its implications for metabolic syndrome. Researchers will present findings on lifestyle interventions and pharmacological strategies to improve insulin sensitivity.

This session will examine the interplay between thyroid disorders and diabetes, focusing on the impact of thyroid function on glycemic control. Clinical implications and management strategies for coexisting conditions will be discussed.

This track will investigate the effects of adrenal disorders on metabolic processes, particularly in relation to diabetes management. Topics will include cortisol's role in glucose metabolism and the implications for treatment.

This session will focus on the role of pancreatic function in the development and progression of diabetes. Researchers will present findings on beta-cell dysfunction and its implications for therapeutic strategies.

This track will explore the hormonal mechanisms involved in glucose metabolism and their relevance to diabetes care. Discussions will include the roles of incretins, glucagon, and other hormones in managing diabetes.

This session will address the multifaceted challenges of metabolic syndrome, particularly its association with diabetes. Experts will discuss prevention strategies and treatment options to mitigate its impact on health.

This track will focus on the prevention and management of complications associated with diabetes, such as neuropathy, retinopathy, and nephropathy. Innovative approaches and best practices in clinical endocrinology will be highlighted.

This session will review the latest developments in diabetes pharmacology, including new drug classes and their mechanisms of action. The focus will be on optimizing treatment regimens for improved patient outcomes.

This track will showcase cutting-edge research in diabetes, including genetic studies, novel biomarkers, and innovative therapeutic approaches. Participants will discuss the implications of these findings for future clinical practice and public health.